Intra-Operative Adductor Canal Blocks
A Randomized Controlled Trial Assessing the Efficacy of Surgeon-performed, Intraoperative Adductor Canal Blocks in Same-Day Discharge Total Knee Arthroplasty
1 other identifier
interventional
80
1 country
1
Brief Summary
Adductor canal blocks (ACB) have been recommended in total knee arthroplasty (TKA) to provide better control of post-operative pain, facilitate early ambulation, and reduce length of stay in the hospital. ACB is typically done before surgery by an anesthesiologist, which may increase time per case, cost, and requires the specialized skills of an anesthesiologist trained in regional anesthesia. Recent studies have suggested that surgeons can safely and reliably administer the adductor canal blocks (sACB) during surgery. However, there is currently very limited data on the clinical efficacy of such sACBs, and no studies assessing this technique in the context TKA that are discharged the same day. As such, this randomized control trial (RCT) is being done to compare sACBs to conventional anesthesiologist-performed adductor canal blocks (aACB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Mar 2023
Typical duration for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2022
CompletedFirst Posted
Study publicly available on registry
November 1, 2022
CompletedStudy Start
First participant enrolled
March 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedApril 25, 2025
April 1, 2025
2.7 years
September 20, 2022
April 22, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Patient Report Pain
Mean Numerical Pain Rating Scale (NPRS) scores on discharge
Up to 24 hours
Pain medication use
morphine equivalents of pain medication
When spinal anesthesia resolves until 24 hours after surgery
Secondary Outcomes (8)
Time to discharge
From PACU to discharge
Admission to Hospital
Up to 24 hours post-operative
Readmission Rate
Up to 24 hours post-operative
Timed Up and Go Test
At discharge
Patient Reported Quality of Recovery
At 24 hours post-operative
- +3 more secondary outcomes
Study Arms (2)
Anesthesiologist-Performed Adductor Canal Block (aACB)
ACTIVE COMPARATORPatients will get a pre-operative adductor canal block performed by an anesthesiologist.
Surgeon-Performed Adductor Canal Block (sACB)
EXPERIMENTALPatients will get an intra-operative adductor canal block performed by the surgeon
Interventions
The patient will undergo a pre-operative single-shot, ultrasound-guided ACB performed by an anaesthesiologist skilled in regional anaesthesia techniques. The ACB will be performed in a dedicated block room, immediately prior to administration of a spinal anaesthetic.
The patient will undergo an intraoperative single-shot ACB performed by the treating surgeon following placement of the TKA components.
Eligibility Criteria
You may qualify if:
- Male and female patients aged 18 years or older
- Primary TKA booked as SDD
- Diagnosis of osteoarthritis
You may not qualify if:
- Inability or refusal to sign informed consent form
- Non-English or French speaking, and no licensed translator, family member or substitute decision maker available.
- Non-osteoarthritis primary diagnosis
- Allergy to analgesic medications
- Contraindication to spinal and/or regional anaesthesia
- Any use of opioid pain medication within four weeks of the index procedure(13)
- Pain catastrophizing scale score ≥16 (8, 9, 14)
- History of cirrhosis
- History renal insufficiency
- History or sensory and/or motor neuropathy to the ipsilateral limb
- Simultaneous, bilateral TKA
- Non-TKA prosthesis
- Scheduled for non-SDD TKA.
- Preoperative varus/valgus of \>10 degrees.
- Planned General Anaesthetic
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ottawa Hospital
Ottawa, Ontario, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon Garceau, MD
The Ottawa Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2022
First Posted
November 1, 2022
Study Start
March 22, 2023
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share